Plus, Eurozone alarms signals...
Plus, the first 10 drugs subject to Medicare price negotiations...
Plus, Exxon calls ESG bluff...
Plus, IPOs are back...
Plus, 1% mortgages...
Plus, home sales continue falling...
Plus, retail stocks are getting rocked...
Plus, 2023's biggest IPO incoming...
Plus, an Instacart IPO...
Plus, 30-year mortgage hits 7%...
Plus, pride backlash hits TGT...
Plus, big oil's next big move...